A A A
MENU

Arrhythmia Alliance (A-A)

Working together to improve the diagnosis, treatment and quality
of life for all those affected by arrhythmias.

Campaigns & Events

News & Updates

ESC Congress 2017

Spotlight 2017: 40 Years of PCI The world's largest cardiovascular congress with over 500 experts sessions and 11 000 abstracts contributing to global awareness of the latest clinical trials and breakthrough discoveries. Abstract submission deadline: 14 Feb Clinical case submission deadline: 1 March Late Breaking Science deadline: 21 March Early Registration fee deadline: 31 May

Read more [external link]

Cardiac tachyarrhythmias and patient values and preferences for their management

Cardiac tachyarrhythmias are recurrent or chronic and in some cases life-threatening conditions. Heart rhythm disturbances are often highly symptomatic and the psychological impact of the disease can be significant. Patients' beliefs and knowledge about their health (and illness), medications, and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses to their illness and treatment; adherence to recommended therapy; and ultimately affects health outcomes. Incorporation of patients' values and preferences for therapy should now be considered as an integral part of the decision-making process and treatment strategy. It is important to acknowledge and understand the impact of cardiac tachyarrhythmias on the patient. To address this issue, a Task Force was convened by the European Heart Rhythm Association (EHRA), and endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the published evidence available, to publish a joint consensus document on patient values and preferences for the management of cardiac tachyarrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice.

Read more [external link]

Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis

A national screening programme for atrial fibrillation is likely to represent a cost-effective use of resources, with systematic opportunistic screening more likely to be cost-effective than systematic population screening. Nurse pulse palpation or modified blood pressure monitors would be appropriate screening tests, with confirmation by diagnostic 12-lead electrocardiography interpreted by a trained GP, with referral to a specialist in the case of an unclear diagnosis. Implementation strategies to operationalise uptake of systematic opportunistic screening in primary care should accompany any screening recommendations.

Read more [external link]

Share

Send us your feedback

Download Resource

To download our information resource and receive regular updates from Arrhythmia Alliance please enter your details below*:

No thanks

*Please note you can unsubscribe from our mailing list at any time

This link will take you to the site

Stay on this site